Vrishketan Sethi

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Vikas Dudeja · 6 shared papers, 2019–2022 · strength 0.78
   • Paper Symphony in chaos: Immune orchestra during pancreatic cancer progression. DOI 10.1016/j.ebiom.2020.102787↗
   • Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
   • Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
2. Tejeshwar Jain · 4 shared papers, 2020–2022 · strength 0.51
   • Paper Symphony in chaos: Immune orchestra during pancreatic cancer progression. DOI 10.1016/j.ebiom.2020.102787↗
   • Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
   • Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
3. Prateek Sharma MD · 4 shared papers, 2020–2022 · strength 0.51
   • Paper Symphony in chaos: Immune orchestra during pancreatic cancer progression. DOI 10.1016/j.ebiom.2020.102787↗
   • Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
   • Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
4. Bhuwan Giri · 4 shared papers, 2021–2022 · strength 0.50
   • Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
   • Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
   • Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
5. Ashok Kumar Saluja · 3 shared papers, 2021–2022 · strength 0.37
   • Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
   • Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
   • Paper Hsp70 modulates immune response in pancreatic cancer through dendritic cells. DOI 10.1080/2162402x.2021.1976952↗
6. Shrey Modi · 2 shared papers, 2021–2022 · strength 0.26
   • Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
   • Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
7. Nipun B. Merchant · 2 shared papers, 2021–2022 · strength 0.24
   • Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
   • Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
8. Utpreksha Vaish · 2 shared papers, 2021–2022 · strength 0.23
   • Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
   • Paper Hsp70 modulates immune response in pancreatic cancer through dendritic cells. DOI 10.1080/2162402x.2021.1976952↗
9. Srikanth Iyer · 2 shared papers, 2021–2022 · strength 0.23
   • Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
   • Paper Hsp70 modulates immune response in pancreatic cancer through dendritic cells. DOI 10.1080/2162402x.2021.1976952↗
10. Sundaram Ramakrishnan · 2 shared papers, 2021 · strength 0.22
    • Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
    • Paper Hsp70 modulates immune response in pancreatic cancer through dendritic cells. DOI 10.1080/2162402x.2021.1976952↗
11. Harrys K.C. Jacob · 2 shared papers, 2021 · strength 0.22
    • Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
    • Paper Hsp70 modulates immune response in pancreatic cancer through dendritic cells. DOI 10.1080/2162402x.2021.1976952↗
12. Anthony R. Ferrantella · 2 shared papers, 2021 · strength 0.22
    • Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
    • Paper Hsp70 modulates immune response in pancreatic cancer through dendritic cells. DOI 10.1080/2162402x.2021.1976952↗
13. Selwyn Maurice Vickers · 1 shared paper, 2022 · strength 0.15
    • Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
14. Vineet Kumar Gupta · 1 shared paper, 2022 · strength 0.15
    • Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
15. Somnath Pandey · 1 shared paper, 2022 · strength 0.15
    • Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
16. Nikita Sharma · 1 shared paper, 2022 · strength 0.15
    • Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
17. Shweta Lavania · 1 shared paper, 2022 · strength 0.15
    • Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
18. John Bart Rose · 1 shared paper, 2022 · strength 0.13
    • Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
19. Sushanth Reddy · 1 shared paper, 2022 · strength 0.13
    • Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
20. Suresh T. Chari · 1 shared paper, 2022 · strength 0.13
    • Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
21. Jashodeep Datta · 1 shared paper, 2022 · strength 0.13
    • Paper Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States. DOI 10.1016/j.hpb.2022.05.003↗
22. Deepak Saxena · 1 shared paper, 2019 · strength 0.12
    • Paper The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy. DOI 10.1053/j.gastro.2018.12.045↗
23. Gerardo A. Vitiello · 1 shared paper, 2019 · strength 0.12
    • Paper The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy. DOI 10.1053/j.gastro.2018.12.045↗
24. George Miller · 1 shared paper, 2019 · strength 0.12
    • Paper The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy. DOI 10.1053/j.gastro.2018.12.045↗
25. Sulagna Banerjee · 1 shared paper, 2021 · strength 0.11
    • Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.